Capsaicyn Derivatives Inhibit Quorum Sensing for Leaky Gut
Solution Overview
Problem
Current treatments for leaky gut syndrome are inadequate, with little evidence supporting the effectiveness of existing methods, and there is a lack of safe and effective recommendations for managing its symptoms, highlighting the need for new compounds and methods to address this condition.
Innovation Solution
The development of compounds of formula I, which inhibit quorum sensing, are used to treat leaky gut and leaky gut syndrome by preventing bacterial pathogenicity and improving intestinal barrier function, thereby reducing symptoms associated with the condition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing treatments are used for leaky gut syndrome, then some symptom management may be achieved, but there is little evidence supporting their effectiveness and they lack safety and efficacy recommendations
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of capsaicin to create capsaicyn derivatives with improved therapeutic properties. Specifically, the invention changes the molecular parameters of the original capsaicin compound to achieve selective inhibition of quorum sensing in pathogenic bacteria while maintaining safety for the gut microbiota, thereby providing a reliable and evidence-based treatment for leaky gut syndrome
2Object-affected harmful factors
If antibiotics are used to treat leaky gut, then bacterial infections may be reduced, but they can make leaky gut worse by causing further imbalance in gut microbiota
Solution Approach 1:
The patent employs an intermediary approach by using quorum sensing inhibition as a mediator to control pathogenic bacteria without directly killing them. The capsaicyn compounds interfere with the bacterial communication system (quorum sensing), preventing pathogenicity and biofilm formation while leaving the gut microbiota balance intact, thus avoiding the harmful effects of traditional antibiotics
Solution Approach 2:
The invention replaces the mechanical/chemical killing mechanism of antibiotics with a signaling interference mechanism. Instead of directly destroying bacteria through antibiotic action, the capsaicyn compounds substitute this approach by blocking quorum sensing signals, thereby preventing pathogenic behavior while preserving the overall microbiota ecosystem
3Object-affected harmful factors
If capsaicin is used to inhibit quorum sensing, then pathogenicity may be reduced, but it may also affect the gut microbiota balance
Solution Approach 1:
The patent applies local quality by creating capsaicyn derivatives with modified molecular structures that provide selective action. The chemical modifications (such as changing the amide group to thioamide or changing the aromatic ring substituents) create compounds with specific local properties that enable selective inhibition of quorum sensing in pathogenic bacteria while sparing beneficial gut microbiota, thus maintaining microbiota balance
Data Source
AI summary
The present invention relates to the treatment of leaky gut. More particularly, the invention provides compounds, and compositions thereof, for use in methods for the treatment of leaky gut and in methods for the treatment of a subclinical increase in gut permeability. The invention further provides compounds, and compositions thereof, for use in methods for the treatment of leaky gut syndrome. The invention further provides compounds, and compositions thereof, for use in methods for the improvement of at least one symptom associated with leaky gut syndrome. The present invention also relates to a method for treatment of leaky gut, a method for treatment of leaky gut syndrome, and a method for improving at least one symptom associated with leaky gut syndrome.